Ezgi Sıla Ahi Üstün

Dr. Ezgi Sıla Ahi Üstün

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2022 in Psychiatry Research
Verified
Journal Article
Closed access
SYSerkan Yazıcı
Serkan Yazıcı
EÜEzgi Sıla Ahi Üstün
Ezgi Sıla Ahi Üstün
RIRıfat Serav İlhan
Rıfat Serav İlhan
MSMeram Can Saka
Meram Can Saka

20 December 2025 in Journal of Affective Disorders
Verified
Journal Article
Closed access
YAYağmur Darben Azarsız
Yağmur Darben Azarsız
AKAybeniz Civan Kahve
Aybeniz Civan Kahve
EÜEzgi Sıla Ahi Üstün
Ezgi Sıla Ahi Üstün
EUEsma Andaç Uzdogan
Esma Andaç Uzdogan
NNNagihan Ayaz Naycı
Nagihan Ayaz Naycı
HKHasan Kaya
Hasan Kaya

1 October 2025 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
EÜEzgi Sıla Ahi Üstün
Ezgi Sıla Ahi Üstün
SYSerkan Yazıcı
Serkan Yazıcı
RIRifat Serav İlHan
Rifat Serav İlHan
MSMeram Can Saka
Meram Can Saka
Despite the fact that there have been many studies on the connection between autism and psychosis, there are still many things that are unknown about the significance of this connection. Recent studies have highlighted the significant overlap between autistic traits and psychotic disorders, yet the clinical implications of these associations are not well understood. This study aims to address this knowledge gap by investigating the links between autistic features and various clinical, functional and behavioural outcomes in individuals with psychosis spectrum. The study included 125 patients who had at least one psychotic episode and who had used antipsychotic medication for most of the treatment period. The clinician conducted face-to-face interviews to evaluate all other clinical characteristics, while self-report scales were employed to evaluate autistic features and quality of life. Complex associations were understood using path analysis. Our study showed that there was a negative association between autistic features and functioning, quality of life and subjective treatment benefit; and a positive association with severity of disorder, severity of anxiety and depression, severity of positive and negative symptoms, suicidal ideation and behaviour, psychiatric comorbidity and number of psychotic episodes. Depression intensity mediated autistic features’ effect on suicidal thoughts. Those who were non-smokers and bullied by peers reported more autistic traits. Taken together, our results highlight the importance of autistic features in the psychosis spectrum. It is clear that there is a significant gap in clinical knowledge regarding the relationship between autism and psychosis and that further improvements in diagnostic tools and treatment options are needed. As our study is cross-sectional in design, speculation about causality is limited and further prospective research is needed.

18 March 2026 in BMC Women's Health
Verified
Journal Article
Open access
EÜEzgi Sıla Ahi Üstün
Ezgi Sıla Ahi Üstün
İTİrem Alkan Tekeş
İrem Alkan Tekeş
YAYağmur Darben Azarsız
Yağmur Darben Azarsız
SYSerkan Yazıcı
Serkan Yazıcı
RIRifat Serav İlHan
Rifat Serav İlHan
MSMeram Can Saka
Meram Can Saka
The relationship between difficulties in emotion regulation and obesity has received a great deal of attention. This study aimed to investigate whether alexithymia affects the success of weight loss in obese women, and whether this is mediated by depression. This prospective longitudinal study was conducted at an obesity centre, where female patients were enrolled in a six-month diet and education programme. At the beginning of the programme, the Toronto Alexithymia Scale (TAS-20) and the Beck Depression Inventory (BDI) were used to assess levels of alexithymia and depression, respectively. Body mass index (BMI) was also calculated. At the end of six months, BMI was calculated again. The mediating role of the depressive symptoms in the association between the alexithymia and the rate of change in BMI(cBMI) was examined using the Process v4.2 package by Andrew F. Hayes, with model 4 being employed. The bootstrap method was used to test the indirect effect. The study included 49 obese women. There was a statistically significant negative correlation between cBMI and TAS-20 score at baseline (ρ= -0.756; p < 0.001), whereas there was no statistically significant correlation between BDI score and cBMI (ρ = 0.037; p = 0.802). In the regression model, alexithymia was independently associated with cBMI (p < 0.001), while depressive symptoms were not independently associated with changes in BMI (p = 0.690). The indirect effect of the TAS-20 score on cBMI via depression was not statistically significant. Higher levels of alexithymia were associated with poorer weight loss outcomes in obese women, independent of depressive symptom severity. The online version contains supplementary material available at 10.1186/s12905-026-04399-x.

20 July 2026 in South African Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
SYSerkan Yazici
Serkan Yazici
EÜEzgi Sıla Ahi Üstün
Ezgi Sıla Ahi Üstün
Background: Lactate dehydrogenase (LDH) plays a crucial role in glucose metabolism by catalysing the conversion of pyruvate to lactate and facilitating lactate utilisation. Given LDH’s central role in energy metabolism, it may serve as a promising biomarker for anxiety disorders. Aim: This study aimed to compare serum LDH levels between patients with generalised anxiety disorder (GAD) and healthy controls (HC) and to examine the associations between LDH levels and clinical features. Setting: Bursa City Hospital: A tertiary hospital in Bursa, Turkey. Methods: This study included 113 participants with GAD and 90 HC. Group comparisons were conducted using an independent samples t-test. Correlations between LDH levels and clinical variables were assessed using the Pearson rank correlation coefficient. To control for the impacts of possible confounding factors on LDH levels, an analysis of covariance (ANCOVA) was conducted. Results: Serum LDH levels were significantly lower in the GAD compared to the HC (157.7 ± 18.7 vs. 173.2 ± 23.3; p: <0.001, t: −5.249, d Cohen: 0.733). The ANCOVA analysis revealed that there was a statistically significant difference in adjusted LDH levels between the control and GAD groups (p < 0.001; mean difference: −15.607; 95% confidence interval [CI]: −21.180 to −9.975). Additionally, LDH levels were negatively and significantly correlated with HAM-A scores (r = −0.218, p = 0.021) and psychic subscale scores (r = −0.250, p = 0.008). Conclusion: These findings support the hypothesis that LDH may represent a potential biomarker and therapeutic target in the clinical management of anxiety. Contribution: This study is the first to report significantly reduced LDH levels in individuals with GAD, highlighting a potential link between altered lactate metabolism and anxiety pathogenesis.